Clinical Trial

An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes

Completed
View on ClinicalTrials.gov →
Summary
This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 participants aged 18-75 years with type 2 diabetes to have a minimum of 20 participants initiate the use of Omnipod M System and the goal of 16 participants completing the 6-week treatment period.
Protocol Amendment History 3 changes
critical Trial completed 2026-05-06
notable Primary completion pushed: 2026-02-27 -> 2026-03-30 2026-04-01
minor Completion pushed: 2026-02-27 -> 2026-03-30 2026-04-01
Trial Details
NCT Number NCT07276776
Lead Sponsor Insulet Corporation
Conditions Type 2 Diabetes Mellitus
Enrollment 40 participants
Start Date 2025-12-12
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05